A Scoping Review on COVID-19-Induced Cardiovascular Complications

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a type of human that resulted in the 2019 disease (COVID-19). Although it was generally categorized as disease, its involvement cardiovascular complications identified from onset. Elevated cardiac troponin levels (a myocardial injury marker) and echocardiograms, which showed anomalous performance patients’ hearts, were noted early case reports obtained Wuhan, China. A couple mechanisms have been proposed to explain COVID-19-induced complications, with systemic inflammation being major focus recently. Chest pain palpitations are among prevalent symptoms moderate severe COVID-19-recovering patients. Cardiac damage potentially occurs due multifactorial factors, include cytokine-induced inflammation, direct cardiotoxicity, disseminated intravascular coagulation (DIC), others. The manifestations arrhythmia, cardiogenic shock, venous thromboembolism, elevated biomarkers. Both long- short-term effects these remain puzzling researchers, substantial evidence yet be gathered reach consensus on severity COVID-19 heart. treatment considerations currently antiarrhythmic management, ACEI or ARB use, anticoagulation, hemodynamic support, immunosuppression. This review aimed outline pathogenesis various well available modalities infection. treatments succinctly explained proper manner ensure understanding.